Impact of switching from triple therapy to dual bronchodilation in COPD: the DACCORD 'real world' study. Vogelmeier CF, Worth H, Buhl R, Criee CP, et al. Respir Res 2022;23:109.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Vogelmeier CF, Worth H, Buhl R, Criee CP, et al. Impact of switching from triple therapy to dual bronchodilation in COPD: the DACCORD 'real world' study. Respir Res 2022;23:109.
PMID: 35501806